Visual Healthcare Opens Product Line to New Scientific Disciplines

Visual Healthcare Opens Product Line to New Scientific Disciplines
Company Breaks New Ground in Clinical Trials With New Solutions for Big Pharma

RENO, NV--(Marketwire - March 22, 2011) - Visual Healthcare Corp. (the "Company") (PINKSHEETS: VSHC) announces that it is breaking new grounds in providing the pharmaceutical industry with highly flexible and secure tools for gathering clinical data from multiple sources around the globe for research purposes. The company has combined its smart inference engine with clinical-specific capture tools to gather physicians' data about patients that are registered in clinical research cohorts.

These tools also have special analytics that make it extremely time-effective for physicians to qualify patients for participating in such research. "Most physicians find it difficult to go through 10,000 files in order to find qualified patients, and often miss this important revenue source," says Gerard Dab, Chairman and CEO. "By storing patient data on one of our smart platforms, a physician will be able to establish a complete list in less than a day, which will make a positive contribution to his bottom line."

The Company has also undertaken to leverage its considerable technology assets outside the field of medicine, and will continue to bring out new products in the course of the year.

Visual Healthcare has had difficult years, like many other knowledge companies, due in no small part to the financial crisis. However, the impending reform of the healthcare system in the U.S. and the need for new methodologies in pharmaceutical research, as well as the necessity for new standards of analytics in scientific endeavor, are creating significant new business opportunities for the company.

"We have restructured, taken major steps to reduce our debt load, and are actively seeking new alliances so we can take full advantage of these new opportunities," concluded Gerard Dab.

The move toward full compliance has been brought on by the sudden demand for Visual Healthcare's cheap, comprehensive and user-friendly technology platforms in the United States' recent core agenda to modernize across the entire healthcare field.

Management has taken the appropriate measures to ensure that Visual Healthcare products remain cutting-edge, including maintaining close relationships with affiliated companies. The Visual Healthcare family of affiliates expects to open respective markets and to assist one another in providing the products and services which have made the Visual Healthcare technologies among the best-performing and highest-rated of their kind.

Complete information on the company's history and financial position can be found in its annual disclosure statement filed with OTC Markets.


Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications, and quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (PINKSHEETS: VMCS), a leader in the field of electronic health records.

For more information, please visit:


Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.